Results 181 to 190 of about 197,173 (246)

CTSZ-dependent anoikis resistance enhances malignant characters of glioblastoma via NF-κB signaling. [PDF]

iScience
Cao Y, Wu W, Wang Y, Zhang B, Zhou H, Zhou M, Chen W, Wang M, Wang J.   +8 more
europepmc   +1 more source

Butyric Acid-Modified m-P14 Peptide Ameliorates Anti-Glomerular Basement Membrane Disease. [PDF]

Int J Mol Sci
Jiang N, Gu YL, Kuang H, Cui Z, Zhao MH, Pang XC, Jia XY.   +6 more
europepmc   +1 more source

Atypical Anti-Glomerular Basement Membrane Disease: A Case for the Occam's Razor? [PDF]

Kidney Int Rep
Ivković V, Kronbichler A.
europepmc   +1 more source

Elevated serum soluble α3(IV)NC1 correlates with kidney injury and worse outcome in patients with anti-glomerular basement membrane disease. [PDF]

Front Immunol
Kuang H, Wan HS, Cui Z, Zhao MH, Jia XY.
europepmc   +1 more source

Relapse of subacute anti-glomerular basement membrane nephritis following self-discontinuation of steroid therapy. [PDF]

CEN Case Rep
Takenaka Y, Hashiba T, Ogura Y, Ando S, Fujii A, Mise N.   +5 more
europepmc   +1 more source

Pulmonary nodules in a case of microscopic polyangiitis: a case report and review of the literature. [PDF]

J Med Case Rep
Deng L, Hong R, Dai Z, Yu J, Chen J, Zhang Y, Chen Z, Wu T, Chen W, Zhong Z, Li J.   +10 more
europepmc   +1 more source

TRIM25 promotes glioblastoma progression by stabilizing HIF-1α expression in normoxia through K11/K29 polyubiquitination. [PDF]

Cell Death Dis
Huang H, Ni K, Li C, Cai M, Liu Y, Zhang J, Shen Y, Chen Y, Sun J, Shao J, Liu Y, Ji W, Jiao J.   +12 more
europepmc   +1 more source

Application of the nephrotoxic serum nephritis model in glomerulonephritis research. [PDF]

Mol Med
Song J, Xu S, Liu W, Sheng J, Zhao Y, Li S, Jia Z, Gong W.   +7 more
europepmc   +1 more source

Ca₁₃Mab-17, a Novel Anti-Cadherin-13 Monoclonal Antibody for Versatile Applications. [PDF]

Antibodies (Basel)
Shimizu K, Suzuki H, Kaneko MK, Kato Y.
europepmc   +1 more source

Surface-Modified Polymeric Nanoparticles for Glioblastoma Therapy: A Review on Targeting Strategies and Delivery of Repurposed Drugs and Off-Label Non-Alkylating Agents. [PDF]

Pharmaceutics
Sousa DM, Loureiro JA, Pereira MC, Ramalho MJ.   +3 more
europepmc   +1 more source